- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.56 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ND6: 6-[4-({4-[(2R)-1-hydroxypropan-2-yl]phenyl}acetyl)piperazin-1-yl]pyridazine-3-carbonitrile(Non-covalent)
- 4 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
ANP.2: 23 residues within 4Å:- Chain A: G.27, G.28, T.29, L.30, K.32, E.146, I.198, G.199, S.200, G.201, G.223, G.224, L.227, F.239, E.240, G.329, N.330, F.331, R.333
- Chain B: I.261
- Ligands: ND6.1, MG.4, EDO.6
26 PLIP interactions:26 interactions with chain A- Hydrogen bonds: A:G.28, A:T.29, A:L.30, A:L.30, A:K.32, A:G.199, A:S.200, A:S.200, A:G.201, A:G.223, A:E.240, A:N.330, A:N.330, A:F.331, A:R.333
- Water bridges: A:K.32, A:K.32, A:R.94, A:E.146, A:E.146, A:N.197, A:N.197, A:N.197, A:G.199
- Salt bridges: A:K.32
- pi-Stacking: A:F.239
ANP.3: 8 residues within 4Å:- Chain A: D.80, L.81, T.82, S.159, V.160, S.161
- Ligands: MG.5, EDO.10
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:T.82, A:T.82, A:S.161
- Water bridges: A:T.82
ANP.14: 23 residues within 4Å:- Chain A: I.261
- Chain B: G.27, G.28, T.29, L.30, K.32, E.146, I.198, G.199, S.200, G.201, G.223, G.224, L.227, F.239, E.240, G.329, N.330, F.331, R.333
- Ligands: ND6.13, MG.16, EDO.18
28 PLIP interactions:28 interactions with chain B- Hydrogen bonds: B:G.28, B:T.29, B:L.30, B:L.30, B:K.32, B:E.146, B:G.199, B:S.200, B:S.200, B:G.201, B:G.223, B:E.240, B:N.330, B:N.330, B:F.331, B:R.333
- Water bridges: B:T.29, B:K.32, B:K.32, B:R.94, B:E.146, B:E.146, B:N.197, B:N.197, B:N.197, B:G.199
- Salt bridges: B:K.32
- pi-Stacking: B:F.239
ANP.15: 8 residues within 4Å:- Chain B: D.80, L.81, T.82, S.159, V.160, S.161
- Ligands: MG.17, EDO.22
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:T.82, B:T.82, B:S.161
- Water bridges: B:Y.156
- 4 x MG: MAGNESIUM ION(Non-functional Binders)
MG.4: 1 residues within 4Å:- Ligands: ANP.2
No protein-ligand interaction detected (PLIP)MG.5: 1 residues within 4Å:- Ligands: ANP.3
No protein-ligand interaction detected (PLIP)MG.16: 1 residues within 4Å:- Ligands: ANP.14
No protein-ligand interaction detected (PLIP)MG.17: 1 residues within 4Å:- Ligands: ANP.15
No protein-ligand interaction detected (PLIP)- 14 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.6: 6 residues within 4Å:- Chain A: L.30, T.69, I.71, R.94, F.95
- Ligands: ANP.2
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.94
EDO.7: 5 residues within 4Å:- Chain A: D.265, Y.266, E.267, R.268
- Chain B: Y.127
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:D.265, A:E.267, A:R.268
EDO.8: 6 residues within 4Å:- Chain A: G.28, T.97, K.128, F.129
- Chain B: D.260, Y.285
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:Y.285, A:K.128
EDO.9: 7 residues within 4Å:- Chain A: I.284, R.289
- Chain B: L.227, S.231, C.236, E.237, S.238
4 PLIP interactions:1 interactions with chain B, 3 interactions with chain A- Water bridges: B:E.237, A:K.286
- Hydrogen bonds: A:R.289, A:R.289
EDO.10: 7 residues within 4Å:- Chain A: L.78, K.79, V.160, S.161, F.162, N.163
- Ligands: ANP.3
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.79, A:S.161, A:N.163
EDO.11: 8 residues within 4Å:- Chain A: F.327, V.328, G.329, L.332, M.339, F.358, L.359, E.362
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:F.327, A:L.359, A:E.362
EDO.12: 6 residues within 4Å:- Chain A: L.243, S.247, V.334, N.335, T.336, L.337
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.335, A:T.336, A:L.337
EDO.18: 6 residues within 4Å:- Chain B: L.30, T.69, I.71, R.94, F.95
- Ligands: ANP.14
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.94
EDO.19: 5 residues within 4Å:- Chain A: Y.127
- Chain B: D.265, Y.266, E.267, R.268
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:D.265, B:E.267, B:R.268
EDO.20: 6 residues within 4Å:- Chain A: D.260, Y.285
- Chain B: G.28, T.97, K.128, F.129
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain B- Water bridges: A:Y.285
- Hydrogen bonds: B:K.128
EDO.21: 7 residues within 4Å:- Chain A: L.227, S.231, C.236, E.237, S.238
- Chain B: I.284, R.289
4 PLIP interactions:1 interactions with chain A, 3 interactions with chain B- Water bridges: A:E.237, B:K.286
- Hydrogen bonds: B:R.289, B:R.289
EDO.22: 7 residues within 4Å:- Chain B: L.78, K.79, V.160, S.161, F.162, N.163
- Ligands: ANP.15
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:K.79, B:S.161, B:N.163
EDO.23: 8 residues within 4Å:- Chain B: F.327, V.328, G.329, L.332, M.339, F.358, L.359, E.362
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:F.327, B:L.359, B:E.362
EDO.24: 6 residues within 4Å:- Chain B: L.243, S.247, V.334, N.335, T.336, L.337
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.335, B:T.336, B:L.337
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tangallapally, R. et al., Development of Brain Penetrant Pyridazine Pantothenate Kinase Activators. J.Med.Chem. (2024)
- Release Date
- 2023-03-29
- Peptides
- Pantothenate kinase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.56 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ND6: 6-[4-({4-[(2R)-1-hydroxypropan-2-yl]phenyl}acetyl)piperazin-1-yl]pyridazine-3-carbonitrile(Non-covalent)
- 4 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-functional Binders)
- 14 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tangallapally, R. et al., Development of Brain Penetrant Pyridazine Pantothenate Kinase Activators. J.Med.Chem. (2024)
- Release Date
- 2023-03-29
- Peptides
- Pantothenate kinase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A